LIPOSA pharmacopuncture, a new herbal formula, affects localized adiposity by regulating lipid metabolism <em>in vivo</em>

Lee,Haesu; Kim,Mi Hye; Jin,Seong Chul; Choi,La Yoon; Nam,Yeon Kyung; Yang,Woong Mo

doi:10.3892/etm.2021.10725

LIPOSA pharmacopuncture, a new herbal formula, affects localized adiposity by regulating lipid metabolism in vivo

Authors:
- Haesu Lee
- Mi Hye Kim
- Seong Chul Jin
- La Yoon Choi
- Yeon Kyung Nam
- Woong Mo Yang
View Affiliations

Affiliations: Department of Convergence Korean Medical Science, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
Published online on: September 13, 2021 https://doi.org/10.3892/etm.2021.10725
Article Number: 1290
Copyright: © Lee et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Localized adiposity is a serious aesthetic problem and a well‑known health risk factor. There is a growing interest in minimally invasive treatment options for excessive fat accumulation, such as pharmacopuncture. LIPOSA is a newly developed pharmacopuncture formula from three natural herbs: The tuber of Pinellia ternata (Thunb.) Breitenb., the whole plant of Taraxacum platycarpum Dahlst. and the root of Astragalus membranaceus Bunge. The present study investigated the effects of pharmacopuncture treatment with LIPOSA on localized adiposity. Male C57BL/6J mice were fed high fat diet for 8 weeks to induce obesity. Then, 100 µl LIPOSA was injected into the left‑side inguinal fat pad at various concentrations, including 13.35, 26.7 and 53.4 mg/ml. Normal saline was injected into the right‑side inguinal fat pad of each mouse as a control. The treatment was performed three times per week for 2 weeks. The weight and histological changes were analyzed in the inguinal fat pad of the obese mice. The expression levels of adipose triglyceride lipase (ATGL), hormone‑sensitive lipase (HSL), autophagy‑related gene (ATG)5, ATG7 and LC3‑II, as lipophagy‑related factors, were evaluated to confirm the lipid‑catabolic effects of LIPOSA. LIPOSA pharmacopuncture markedly decreased the weight of the fat tissue and the size of the adipocytes in the inguinal region of the mouse models of obesity in a dose‑dependent manner. The expression levels of ATGL, HSL, ATG5, ATG7 and LC3‑II were significantly increased by the LIPOSA treatments. In addition, LIPOSA pharmacopuncture was found to decrease the expression levels of ACC, PPAR‑γ and PEPCK. The results indicated that subcutaneous injection of LIPOSA can degrade local fat and induce lipophagic and lipase activation effects. In addition, lipid metabolism related to fat accumulation was regulated by the LIPOSA treatment. The present study suggests that LIPOSA pharmacopuncture can be a non‑surgical alternative in the treatment of localized adiposity.

View Figures

View References

1	Sarwer DB, Wadden TA and Foster GD: Assessment of body image dissatisfaction in obese women: Specificity, severity, and clinical significance. J Consult Clin Psychol. 66:651–654. 1998.PubMed/NCBI View Article : Google Scholar
2	Moya AP and Sharma D: A modified technique combining vertical and high lateral incisions for abdominal-to-hip contouring following massive weight loss in persistently obese patients. J Plast Reconstr Aesthet Surg. 62:56–64. 2009.PubMed/NCBI View Article : Google Scholar
3	Black DW, Shaw M, McCormick B and Allen J: Pathological gambling: Relationship to obesity, self-reported chronic medical conditions, poor lifestyle choices, and impaired quality of life. Compr Psychiatry. 54:97–104. 2013.PubMed/NCBI View Article : Google Scholar
4	Friedmann DP, Avram MM, Cohen SR, Duncan DI, Goldman MP, Weiss ET and Young VL: An evaluation of the patient population for aesthetic treatments targeting abdominal subcutaneous adipose tissue. J Cosmet Dermatol. 13:119–124. 2014.PubMed/NCBI View Article : Google Scholar
5	Berry MG and Davies D: Liposuction: A review of principles and techniques. J Plast Reconstr Aesthet Surg. 64:985–992. 2011.PubMed/NCBI View Article : Google Scholar
6	Reeds DN, Mohammed BS, Klein S, Boswell CB and Young VL: Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: A randomized, controlled trial. Aesthet Surg J. 33:400–408. 2013.PubMed/NCBI View Article : Google Scholar
7	Noh Y and Heo CY: The effect of phosphatidylcholine and deoxycholate compound injections to the localized adipose tissue: An experimental study with a murine model. Arch Plast Surg. 39:452–456. 2012.PubMed/NCBI View Article : Google Scholar
8	Kim SY, Shin IS and Park YJ: Effect of acupuncture and intervention types on weight loss: A systematic review and meta-analysis. Obes Rev. 19:1585–1596. 2018.PubMed/NCBI View Article : Google Scholar
9	Huang YC, Tsay HJ, Lu MK, Lin CH, Yeh CW, Liu HK and Shiao YJ: Astragalus membranaceus-polysaccharides ameliorates obesity, hepatic steatosis, neuroinflammation and cognition impairment without affecting amyloid deposition in metabolically stressed APPswe/PS1dE9 mice. Int J Mol Sci. 18(2746)2017.PubMed/NCBI View Article : Google Scholar
10	Kim YJ, Shin YO, Ha YW, Lee S, Oh JK and Kim YS: Anti-obesity effect of Pinellia ternata extract in Zucker rats. Biol Pharm Bull. 29:1278–1281. 2006.PubMed/NCBI View Article : Google Scholar
11	Yang HY and Lee SG: Effects of dandelion (Teraxacum platycarpum) with various extracting method on antioxidative capacity, lipid metabolism in diet-induced obese rats. Korean J Orient Physiol Pathol. 25:48–54. 2011.(In Korean).
12	Heo J: Dongeuibogam. 1613.
13	Pinto H: Local fat treatments: Classification proposal. Adipocyte. 5:22–26. 2016.PubMed/NCBI View Article : Google Scholar
14	Bray GA, Fruhbeck G, Ryan DH and Wilding JP: Management of obesity. Lancet. 387:1947–1956. 2016.PubMed/NCBI View Article : Google Scholar
15	Engin A: Fat cell and fatty acid turnover in obesity. Adv Exp Med Biol. 960:135–160. 2017.PubMed/NCBI View Article : Google Scholar
16	Haczeyni F, Bell-Anderson KS and Farrell GC: Causes and mechanisms of adipocyte enlargement and adipose expansion. Obes Rev. 19:406–420. 2018.PubMed/NCBI View Article : Google Scholar
17	Lee HJ, Lee MH, Lee SG, Yeo UC and Chang SE: Evaluation of a novel device, high-intensity focused ultrasound with a contact cooling for subcutaneous fat reduction. Lasers Surg Med. 48:878–886. 2016.PubMed/NCBI View Article : Google Scholar
18	Cingolani F and Czaja MJ: Regulation and functions of autophagic lipolysis. Trends Endocrinol Metab. 27:696–705. 2016.PubMed/NCBI View Article : Google Scholar
19	Singh R and Cuervo AM: Lipophagy: Connecting autophagy and lipid metabolism. Int J Cell Biol. 2012(282041)2012.PubMed/NCBI View Article : Google Scholar
20	Martinez-Lopez N, Garcia-Macia M, Sahu S, Athonvarangkul D, Liebling E, Merlo P, Cecconi F, Schwartz GJ and Singh R: Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the brown adipose tissue and liver. Cell Metab. 23:113–127. 2016.PubMed/NCBI View Article : Google Scholar
21	Kim JH, Kim OK, Yoon HG, Park J, You Y, Kim K, Lee YH, Choi KC, Lee J and Jun W: Anti-obesity effect of extract from fermented Curcuma longa L. through regulation of adipogenesis and lipolysis pathway in high-fat diet-induced obese rats. Food Nutr Res. 60(30428)2016.PubMed/NCBI View Article : Google Scholar
22	Ryden M and Arner P: Subcutaneous adipocyte lipolysis contributes to circulating lipid levels. Arterioscler Thromb Vasc Biol. 37:1782–1787. 2017.PubMed/NCBI View Article : Google Scholar
23	Kojta I, Chacinska M and Blachnio-Zabielska A: Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 12(1305)2020.PubMed/NCBI View Article : Google Scholar
24	Janovska A, Hatzinikolas G, Staikopoulos V, McInerney J, Mano M and Wittert GA: AMPK and ACC phosphorylation: Effect of leptin, muscle fibre type and obesity. Mol Cell Endocrinol. 284:1–10. 2008.PubMed/NCBI View Article : Google Scholar
25	Marion-Letellier R, Savoye G and Ghosh S: Fatty acids, eicosanoids and PPAR gamma. Eur J Pharmacol. 785:44–49. 2016.PubMed/NCBI View Article : Google Scholar
26	Franckhauser S, Muñoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B and Bosch F: Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 51:624–630. 2002.PubMed/NCBI View Article : Google Scholar